^
BIOMARKER:

FANCL mutation

i
Other names: FA Complementation Group L, Fanconi Anemia-Associated Polypeptide Of 43 KDa, RING-Type E3 Ubiquitin Transferase FANCL, Fanconi Anemia Complementation Group L, E3 Ubiquitin-Protein Ligase FANCL, Fanconi Anemia Group L Protein, PHD Finger Protein 9, FAAP43, PHF9
Entrez ID:
News
Twitter
Trials
FANCL mutation
Ovarian Cancer
olaparib
Sensitive: B - Late Trials
ESMO 2021 - 4 weeks
FANCL mutation
Prostate Cancer
olaparib
Sensitive: A2 - Guideline
FANCL mutation
HER2 Negative Breast Cancer
durvalumab
Sensitive: C2 – Inclusion Criteria